Showing results (21-30 of 261) with videos related to
Sort By:
Pageof 27
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.Microbiology and Immunology|November 23, 2006
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patientsYi Wang, Yukari Takao, Mamoru Harada, et al.Asian Pacific Journal of Allergy and Immunology|December 6, 2008
A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patientsNobukazu Komatsu, Mamoru Harada, Masami Nakagawa, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapyHiroko Takedatsu, Takashi Okamura, Kohji Yoshimoto, et al.Cancer Immunology, Immunotherapy : CII|August 29, 2006
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype allelesTakafumi Minami, Satoko Matsueda, Hiroko Takedatsu, et al.International Journal of Oncology|March 11, 2004
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patientsYuki Ishihara, Mamoru Harada, Koichi Azuma, et al.The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patientsShigeki Shichijo, Masaaki Ito, Kouichi Azuma, et al.Oncology Reports|April 22, 2008
Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patientsMingyue Jin, Yoshihiro Komohara, Shigeki Shichijo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomaYi Wang, Mamoru Harada, Hirohisa Yano, et al.Pageof 27